Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
29,349
Total Claims
$2.0M
Drug Cost
876
Beneficiaries
$2,334
Cost/Patient
Risk Score Breakdown 26/100
Score components are additive. Read full methodology
Peer Comparison vs. 1,080 Hospice and Palliative Care providers
-91%
Opioid rate vs peers
3.0% vs 33.2% avg
+282%
Cost per patient vs peers
$2,334 vs $611 avg
+126%
Brand preference vs peers
15.2% vs 6.7% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
3.0%
Opioid Rate
868
Opioid Claims
$22K
Opioid Cost
9.7%
Long-Acting Rate
Brand vs Generic
Brand: 4,427 claims · $1.3M
Generic: 24,719 claims · $700K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 732 | $214K |
| Rivaroxaban | 216 | $71K |
| Sitagliptin Phosphate | 219 | $66K |
| Dulaglutide | 81 | $55K |
| Insulin Aspart | 194 | $54K |
| Rifaximin | 28 | $49K |
| Paliperidone Palmitate | 17 | $46K |
| Collagenase Clostridium Hist. | 37 | $44K |
| Mirabegron | 165 | $39K |
| Insulin Detemir | 133 | $37K |
| Memantine Hcl | 448 | $31K |
| Tofacitinib Citrate | 11 | $30K |
| Risperidone Microspheres | 12 | $25K |
| Linagliptin | 95 | $25K |
| Insulin Aspart | 78 | $24K |
Prescribing Profile
Patient Profile
76
Avg Age
58%
Female
3.00
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About